about
Myopic choroidal neovascularisation: current concepts and update on clinical managementThe Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune UveitisCopy number variation of age-related macular degeneration relevant genes in the Korean populationThe development of recurrent choroidal neovascularization in a patient with choroidal coloboma.Stellate ganglion block increases blood flow into the optic nerve head and the peripapillary retina in human.Anatomical and functional characteristics in atrophic maculopathy associated with spinocerebellar ataxia type 7.Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.Inhibitory effect of YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat.Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.Macular capillary blood flow in patients with diffuse diabetic macular edema without vitreomacular traction.Case of bilateral retinal neovascularization associated with chronic idiopathic myelofibrosis.Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate UveitisDetection of retinitis pigmentosa by differential interference contrast microscopyThe anti-angiogenic effect of chlorogenic acid on choroidal neovascularizationComparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative studyClinical features and course of ocular toxocariasis in adults.Hereditary and clinical features of retinitis pigmentosa in Koreans.Immunopathogenesis of ocular Behçet's diseaseComparison of features on SD-OCT between acute central serous chorioretinopathy and exudative age-related macular degeneration.Melissa officinalis extract inhibits laser-induced choroidal neovascularization in a rat model.Candida albicans endophthalmitis in a patient with a non-functioning pituitary adenoma evolving into Cushing׳s disease: A case report.Intravitreal ranibizumab for subfoveal choroidal neovascularization from age-related macular degeneration with combined severe diabetic retinopathyThe diagnostic application of targeted re-sequencing in Korean patients with retinitis pigmentosaClinical outcomes of cyclosporine treatment for noninfectious uveitisSubretinal transplantation of putative retinal pigment epithelial cells derived from human embryonic stem cells in rat retinal degeneration model.Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative ProteomicsEfficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea.The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication.A case of carotid aneurysm in familial retinal arterial tortuosity.Influences of faculty evaluating system on educational performance of medical school faculty.Targeted resequencing of candidate genes reveals novel variants associated with severe Behçet's uveitisThe Structure-Function Relationship between Macular Morphology and Visual Function Analyzed by Optical Coherence Tomography in Retinitis PigmentosaChlorogenic acid supplementation improves multifocal electroretinography in patients with retinitis pigmentosa.Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis.Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance.Association of cytomegalovirus with idiopathic chronic anterior uveitis with ocular hypertension in Korean patients.Endogenous endophthalmitis in the Korean population: a six-year retrospective study.Long-term results of fluocinolone acetonide intravitreal implant in Behçet intractable posterior uveitis.Risk factors for intraocular involvement in patients with primary central nervous system lymphoma.
P50
Q26865884-E07AD7C8-232F-463C-8966-1B608E6EB2F5Q28551977-05080405-7933-4E94-871D-2293D118F276Q28732075-7FAB4054-E213-4678-B811-D16A9BBBAA87Q31000600-A99C8DB6-E80F-4FA1-B14B-5D9A7399F7ADQ31028524-6FBFFFDA-4C30-4972-AE16-8858155D0816Q33214511-9C521F45-F0E6-4F81-A497-3B1E8480CD33Q33303539-61C873DD-9225-437A-8A0B-00864A1E63B6Q33306801-8B299C54-4031-4572-AC24-DC09E240C221Q33320965-F05A7D95-900F-4DBC-9272-BA77E5F1CFB0Q33440716-E57B19FD-F034-471F-A87F-AEBAB2102FBFQ33455399-BC655B18-EE0A-4324-A75B-077AE0A85B9BQ33551185-619EA376-8F3E-4C18-A8CE-A0B6986107BAQ33561505-0BC2A6FE-83FF-415D-A306-CF8574ACBAD5Q33584338-025FD225-B3AA-476D-BE0D-E3460039DAAAQ33598413-592ED4E3-A6F7-408B-B04B-C0681CAAC244Q33701661-FA848378-F530-4F56-8FD1-462A5DD67BD5Q33747858-AD1BFB5F-BFE1-4297-947D-6060DDCD85FCQ33879772-F0513F88-86BD-46A5-9EEC-4D366BB7FE5BQ33908937-6F7CE992-0A7A-420C-B117-F67F08EA6AB1Q34327799-5C8E8116-267F-4C5C-B423-3144A8F1CF05Q34338680-95B83993-038A-411B-BB28-E9E07132B83FQ34436162-12683726-996B-451E-8C88-D6611AC1C599Q35126845-04B03744-8969-4CB0-A3D1-BD3EB2B83542Q35686366-506BF3C8-E31F-4CD7-A5EE-F32BD588C416Q35707965-ECDB65DE-BAC4-49FF-8109-150489E4F55AQ35767909-B3E221DF-29CE-412F-A3F3-E1BA790265B8Q36311077-F43BFEF6-5CEF-46EC-8691-486A5D1A6827Q36949135-A2994F32-CB7A-49F6-9BCE-7FF25AD81FDBQ37078185-19173D38-1C6B-4F53-93D3-B53DE5D7AC74Q37128304-3BAEE302-0229-4B84-96F6-1D7FC35CF6A2Q37242573-56494866-CB4C-409D-945D-DC91F1023668Q37258243-969090A7-AB1B-4723-B63A-11CAF4F24134Q37400441-7C1221AF-91B6-4107-B0D4-F7CBEF1D6EA0Q37473588-7A55FC6A-F0F0-4725-B905-DA10CB032FD3Q37902663-0C5CF44E-A0E5-4193-9D44-93B96E1D35A6Q37981565-382AEBB4-C98D-41EA-8FA7-A3BA70965E93Q38088376-14F48739-185B-4A3C-98C0-AC85B64F40C8Q38140600-C8FF897A-BA20-4676-9C80-83B14030A60AQ38215029-083DBB4A-5426-4678-BB14-B9B4C4844C1DQ38239533-E833FF92-DE0A-40C0-B876-AC09ADF53364
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hyeong Gon Yu
@ast
Hyeong Gon Yu
@en
Hyeong Gon Yu
@es
Hyeong Gon Yu
@nl
Hyeong Gon Yu
@sl
type
label
Hyeong Gon Yu
@ast
Hyeong Gon Yu
@en
Hyeong Gon Yu
@es
Hyeong Gon Yu
@nl
Hyeong Gon Yu
@sl
prefLabel
Hyeong Gon Yu
@ast
Hyeong Gon Yu
@en
Hyeong Gon Yu
@es
Hyeong Gon Yu
@nl
Hyeong Gon Yu
@sl
P106
P1153
56589187000
P214
1855157162095478980007
P31
P496
0000-0002-1795-202X
P7859
viaf-1855157162095478980007